Sanofi, Abbott Fail To Halt Release Of Generic Tarka

Law360, New York (June 7, 2010, 7:52 PM EDT) -- Sanofi-Aventis Deutschland GmbH and Abbott Laboratories have lost their bid to block Glenmark Ltd. from releasing a recently approved generic version of Abbott's high blood pressure drug Tarka.

Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey ruled Monday that the public interest — as well as Glenmark's likelihood of success on its defense that U.S. Patent Number 5,721,244 is invalid due to obviousness — weigh in favor of denying the plaintiffs' application for a preliminary injunction and temporary restraining...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.